Human Vaccines and Immunotherapeutics

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination

When knowledge is not enough: Changing behavior to change vaccination results

Consumer reporting of adverse events following immunization

Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line

Commentary on "Parental vaccine-hesitancy: Understanding the problem and searching for a resolution"

Commentary on "Maternal immunization: Clinical experiences, challenges, and opportunities in vaccine acceptance"

Clarification of "Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines"

Challenges and changes: Immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations

Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4

Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011